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The work group on cardiovascular and endocrine effects was asked to review the current state of
knowledge about children's windows of vulnerability to developmental toxicants and to recommend
how that information may be used to improve risk assessment and public health. We considered
differences between structural defects, where periods of vulnerability are rather well defined, and
functional defects, where periods of vulnerability are quite elusive. Key words: developmental
toxicity, endocrine, heart, teratogen. - Environ Health Perspect 1 08(suppl 3):569-571 (2000).
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The work group on cardiovascular and
endocrine effects reviewed the current state of
knowledge about children's windows of
vulnerability to developmental toxicants
and made recommendations for how that
information may be used to improve risk
assessment and public health. The three back-
ground papers by Hoet and Reusens (1),
Osmond (2), and Sadler (3) form an essential
base for our ensuing discussions, and little of
the information in those articles will be reiter-
ated here. We cite only a few references in
support of particular points.
There are windows of vulnerability for
structural alterations; whereas the inception
of vulnerability is often poorly defined, the
end of vulnerability is usually well defined.
The principal reason for uncertainty about
the initiation of the vulnerable period is that
cascades of gene action and development
exist, but their sequences and timing are not
yet fully worked out. The closer we look, the
more evident it is that often there is not a
uniform response within a given "window."
There may be peaks and valleys, or various
slopes of sensitivity, within the period of
vulnerability. Although there is increased
recognition of the role of regulatory genes
and gene cascades, its also evident that the
same gene has different roles and timing in
different tissues.
We believe that the question ofwho might
be susceptible to teratogenesis is largely deter-
mined by the genome. Genomic influence on
the expression of teratogenesis has been
repeatedly reported in laboratory animals (4),
and at least one recent study notes the interac-
tion between a teratogen and a specific gene in
the mouse (5). There is anecdotal evidence
that teratogen-gene interaction occurs in
humans as well (6,7). Drugs and genes may
not only interact, but one may mimic the
other [e.g., sonic hedgehog and retinoids (3)].
In the future, epidemiological and genetic
study combined may identify subgroups of
children who are more vulnerable through
environment-genome interaction.
For humans, the definition ofwindows of
vulnerability for functional aberrations is
more elusive than for structural anomalies.
Currently, windows of vulnerability are con-
sidered the period of liability that extends
from at least the second trimester of gesta-
tion, and probably the first trimester,
onward. Preconceptional liability remains
more speculative.
The term "developmental toxicant" is
used rather loosely to encompass true terato-
gens, embryotoxins, and fetotoxins.
Recognized human teratogens cause rather
specific syndromes, although it is possible
that environmental agents may also act to
interfere with development in such a way as
to produce single malformations or particu-
lar functional deficits. For prenatal exposure,
we restricted our consideration to maternal
exposure; paternally mediated, environmen-
tal effects were considered unsubstantiated.
It was noted that additive or synergistic
exposure effects are largely unexplored, par-
ticularly in humans. There is abundant evi-
dence that nutrition plays a key role in the
etiology and prevention of birth defects and
in the consequent health of an individual. In
the case of the conceptus, the route and
dynamics of nutrition change during gesta-
tion. Initially by simple diffusion, nutrition
is then controlled by the yolk sac (in the
rodent) and ultimately by the chorio-
allantoic placenta.
Cardiovascular
We distinguished between structure and
function in the cardiovascular system. In this
system, a structurally abnormal heart may
have abnormal function. For this system,
"functional abnormality" refers more specifi-
cally to aberrant function or disease of the
structurally normal heart.
Cardovascuar Stmcture
Each particular defect will have its own critical
window of vulnerability. As the details of car-
diogenesis become better understood, these
periods of vulnerability will be better defined.
Further investigation in this area should be
supported. More information on possible
environmental interactions with gene cas-
cades in cardiogenesis would enhance our
ability to detect potential teratogens.
However, we believe there is already
enough known about cardiovascular develop-
ment that it is no longer tenable to lump
heart defects together as though they were a
single entity. Rather they should be consid-
ered individual defects or mechanistically
related groups of defects (8). As for the partic-
ular mechanisms involved in cardiogenesis,
neural crest migration, endocardial cushion
development, and mesenchymal-myocardial
transformation would seem to be the most
important areas on which to concentrate.
Alterations of hemodynamics may affect
structural cardiovascular development, but
associating this with environmental exposure
is uncertain. In distinction to other organs
such as the brain, apoptosis appears to have a
very limited role in normal cardiogenesis
(only in the atrial septum). An appropriate
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strategy for epidemiological study would
focus on the most common structural lesions
as individual entities. The detection of rare
lesions associated with rare exposures (e.g.,
lithium and Ebstein malformation) could be
left to the "alert practitioner."
Epidemiological studies to date have
largely failed to verify environmental agents as
causes of cardiac defects, but they have raised
some question about particular exposures and
particular defects (5). Several past surveys have
encountered problems with sample size, mis-
classification of exposure, and inappropriate
grouping of outcomes. More refined data on
actual timing of exposure would be helpful in
determining any cause-effect relationships for
specific defects. For example, the recurring
controversy over a putative link between
steroid exposure and cardiac malformation
might be resolved by more precise informa-
tion on the timing of exposure. Nonetheless,
we recommend not narrowing the current
definition of the window of vulnerability to
cardiac malformation (fertilization to 8 weeks,
most lesions at 3-5 weeks).
We recommend that patent ductus arte-
riosus (PDA) should be treated separately
from true structural defects of the heart and
great vessels. Because prostaglandin inhibition
affects ductal closure, we think that PDA is
better viewed as a functional defect.
Current protocols, for both laboratory
animal and human investigation, largely miss
what we believe is important information.
Standard developmental toxicology studies
should include not only tabulation of early
losses (miscarriage and resorption) but a char-
acterization of their morphology or reason for
loss. This would involve the examination- of
conceptuses before their in utero death or, in
the case of humans, collecting sonographic
and fetal autopsy data. An understanding of
why a conceptus died would surely enhance
our ability to comprehend mechanisms of
developmental toxicity.
Cardiovascular Function
Acute effects. Cardioactive drugs can affect
cardiac function of the fetus, especially in the
third trimester, but it is not yet clear what, if
any, long-range effects may result. Studies to
collect this information should be supported.
Some suggestive lines of evidence for func-
tional impairment of cardiac function from
fetal exposure include four that we mention
here. First, cortisol inhibits cardiac myocyte
replication and simulates the postnatal
growth pattern (hypertrophy) of the heart
(10). Second, in rats, nicotine affects sinoa-
trial reactivity to hypoxia without impairing
cardiac conduction per se. This possibly
explains the increased vulnerability of infants
of mothers who smoke to sudden infant
death syndrome (11). Third, thyroid status
has been linked to muscle development.
Thyroid hormone is required for proper
development of the adult phenotype of
myosin heavy chain of muscle (12).
Although the experiment in rats was con-
ducted on skeletal muscle, it may apply to
cardiac muscle as well. Fourth, maternal
lupus erythematosus is associated with fetal
heart block; however, the biological basis for
this observation remains obscure (13).
The role of the adrenals and kidneys,
through their control of fetal blood pressure,
in affecting development (e.g., weight and
hemodynamics) is being explored (14), but
long-term effects are largely unexplored.
Cardiomyopathy may be genetic, infectious,
or consequent to structural defects. Whether
it might also be consequent to chemical
exposure is unknown.
Delayed effects. We reviewed with interest
the programming hypothesis that early
changes lead to late effects (2). Low birth
weight has been associated with an increased
risk of developing hypertension, coronary
artery disease, and diabetes-but why? The
principal gap in knowledge is uncertainty
about the etiologies and mechanisms of
intrauterine growth restriction (IUGR).
Morphological and functional studies of the
placenta are underutilized in tackling the
problem of IUGR. Early protein deprivation
also appears to have long-term effects (1), but
we need to understand more about basic
mechanisms to generate better hypotheses.
Maternal birth weight correlates with her
infant's birth weight (2)-but again, why?
Certainly, we need a better understanding of
possible links between lifestyle factors and
cardiovascular effects [e.g., smoking and fetal
cardiac myohyperplasia (15) or possible liabil-
ity to later cardiovascular disease; cocaine
exposure and possible liability to later cardio-
vascular disease].
We must distinguish between prematurity
and IUGR because the mechanisms involved
are quite different. There should also be differ-
entiation between IUGR with and without
postnatal catch-up growth because the former
is likely to represent interference with late ges-
tational nutrition, whereas the latter may stem
from early gestational insult. Assessment of
prenatal and postnatal growth should indude
weight, length (height), and head circumfer-
ence as a minimum. More extensive growth
profiling ofhuman fetuses, induding limb and
visceral measurements, has shown that reason-
ably distinct patterns of growth aberration can
be correlated with etiologic factors (16).
Endocrine
Endocrne Structure
To the best of our knowledge, structural
defects of the endocrine glands (e.g., agenesis
of any gland, annular pancreas, pancreatic
nesidioblastosis, lingual thyroid, and aberrant
adrenal nodules) have not been related to
environmental exposures. Goiter, which does
have environmental exposure antecedents, is
viewed as a functional defect.
Endocrine Function
Pancreas. Low birth weight appears to be
associated with an increased risk for later
development of diabetes mellitus (2). Why
this is so remains a mystery. Maternal dia-
betes has been associated with a variety of dif-
ferent patterns of defects. We wondered if the
particular, and usually nonoverlapping, pat-
terns of defects are determined by interaction
between diabetes and the genome or other
environmental factors. Hyperglycemia in ges-
tation can increase birth weight (obesity and
macrosomia), but brain weight is normal for
age (17). Diabetes mellitus may also be asso-
ciated with IUGR, particularly with the
co-occurrence of structural defects. The long-
term consequences of these aberrations merit
continued study.
Thyroid Goiter has long been associated
with dietary iodine deficiency. Thyroid
function is amenable to transplacental modi-
fication (e.g., treatment of fetal thyrotoxico-
sis). This signals a warning against
nontherapeutic exposure to thyroactive
drugs and chemicals. Thyroid function also
affects fetal growth and perhaps cardiovascu-
lar development. Thyroid status has been
linked to skeletal, and perhaps cardiac,
muscle development (12).
Adrenal There is extensive literature on
the development of the adrenal glands and
their cytomorphology. Nonetheless, we need
to know more about fetal adrenal function
and response to environmental factors, espe-
cially stress. There are reports that fetal stress
(e.g., hypoxia and chorioamnionitis) is asso-
ciated with increased bulk of the fetal
adrenal cortex (18,19). However, the func-
tional implications of these observations are
unknown. Rudolph et al. (10) demonstrated
the effect of cortisone on cardiomyocyte
replication. Exposure to androgenic steroids
affects genital development. The experience
with diethylstilbestrol leading to both mor-
phologic alteration and increased risk of
tumor formation has raised concern about
the deleterious effects of other steroids.
Pituitary. Pituitary function is affected in
a number of central nervous system malfor-
mations. The importance of the complex
interaction among hormones (i.e., control
and feedback functions) in the evolution of
other structural abnormalities has not been
adequately studied. Aberrations of pituitary
axis function are of considerable importance
in the practice of pediatric endocrinology. To
what extent these aberrations may be due to
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prenatal or postnatal environmental exposure
is uncertain.
Parathyroid. Calcification abnormalities
are difficult to interpret as an endocrinologi-
cal function, as they may involve mechanisms
other than parathyroid function. We know of
no suggestion of environmental induction of
abnormal parathyroid function, but we did
not fully explore the issue.
Thymus, pineal, and gonads. We did
not discuss the function of these organs, or
their discussion was deferred to other work-
shop sessions.
Conclusions
Many questions remain as to how early in
gestation the various endocrine systems are
active and important to the developmental
process. The fetal window of vulnerability to
endocrine dysfunction appears to be primar-
ily the third trimester, but the second
trimester is undoubtedly also important.
Damage from first-trimester exposure is more
problematic. Endocrine effects from environ-
mental exposure could occur at any postnatal
age, and although a number of such effects
may be reversible, others may be permanent.
Pharmacological/chemical disruption of
endocrine function is possible, but the full
range of possibility has yet to be explored. Are
effects only during exposure? What is the
potential for recovery? Are there long-range
effects? Are there permanent effects (e.g., on
brain development or function; or on immune
or reproductive function)? Screening for
endocrine disruptors should indude assessment
of prenatal development. Diurnal and post
cibum variation in hormone levels can compli-
cate the collection and interpretation of data.
High-priority targets for research should
include: a) thyroid, which is affected by envi-
ronmental exposures (e.g., polychlorinated
biphenyls); b) pancreas, especially P-cell
function and its interaction with nutrition;
c) adrenal stress response and cortisol pro-
duction; and d) pituitary and the neuro-
endocrine axis.
We considered the appropriateness of
various animal models for studying endocrine
effects. For thyroid, commonly used animal
models should be quite useful. For pancreatic
function, rats are not appropriate as animal
models because they can regenerate ,B-cells.
For other hormones, there is insufficient
information to comment, and although it was
noted that steroids are teratogenic in certain
strains of laboratory animals, similar patterns
of teratogenicity have not been confirmed in
humans.
We expressed a number of qualifications
about extrapolating from laboratory animal
data to the human situation. We agreed that
uniformity of effects across species carries
greater weight for predicting human effects
than does abnormality occurring in only one
species. When comparing studies in different
species, it is essential to match for the compa-
rable stage of development in each species.
Animal models should be chosen for as much
pharmacokinetic and metabolic similarity to
humans as possible.
We noted that there are distinctions to be
made among statistical, biological, and social
significance of a finding of developmental
toxicity. Although the maxim that an ounce
of prevention is worth a pound of cure is
undoubtedly true, in setting priorities for
regulatory action, greater weight should be
placed on those agents with proven develop-
mental toxicity as opposed to those with only
hypothetical toxicity. It is unlikely that there
are currently any undetected potent develop-
mental toxicants; this was thought to apply
more certainly for structural aberrations but
also for functional aberrations. Rather, the
possibility is greater that there are undetected
low-level toxicants and agents with delayed
effects. We urge support of long-range
studies linking relatively uncommon and/or
delayed outcomes to exposure; these studies
will be important to our understanding of
the particular vulnerability of children to
developmental toxicants.
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